The SRF’s CONQUER Registry has reached an important milestone with the addition of University of Chicago as its 20th participating site, further strengthening the nation’s leading longitudinal scleroderma patient registry and biosample repository.
Since its launch by the SRF in 2018, CONQUER has enrolled more than 1,400 patients, and become the gold standard scleroderma patient registry in the U.S.
Each new site expands the diversity and depth of clinical data and biospecimens available to investigators, accelerating discoveries about disease progression, treatment response, and the biological differences between patients.
Today, thanks to the support of patients and all participating centers, CONQUER is better positioned than ever to advance precision medicine and help identify which therapies work best for which patients—and why.
